17
H index
25
i10 index
1185
Citations
University of Pennsylvania | 17 H index 25 i10 index 1185 Citations RESEARCH PRODUCTION: 41 Articles 17 Papers 3 Books 6 Chapters EDITOR: Books edited RESEARCH ACTIVITY: 36 years (1982 - 2018). See details. MORE DETAILS IN: ABOUT THIS REPORT: Permalink: http://citec.repec.org/pda291 |
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Patricia M. Danzon. | Is cited by: | Cites to: |
Working Papers Series with more than one paper published | # docs |
---|---|
NBER Working Papers / National Bureau of Economic Research, Inc | 10 |
Monograph / Office of Health Economics | 3 |
Working Papers / The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State | 2 |
Year | Title of citing document |
---|---|
2024 | . Full description at Econpapers || Download paper |
2023 | Who pays for gifts to physicians? Heterogeneous effects of industry payments on drug costs. (2022). Newham, Melissa ; Valente, Marica. In: Papers. RePEc:arx:papers:2203.01778. Full description at Econpapers || Download paper |
2024 | The Impact of Acquisitions on Inventors Turnover in the Biotechnology Industry. (2022). Riccaboni, Massimo ; van Lidth, Jeroen ; Parisi, Federica ; Verginer, Luca. In: Papers. RePEc:arx:papers:2203.12968. Full description at Econpapers || Download paper |
2023 | Exploring the Dynamics of the Specialty Insurance Market Using a Novel Discrete Event Simulation Framework: a Lloyds of London Case Study. (2023). Tua, Alan ; Feng, Zhe ; Kam, Keith ; Ahmed, Akhil ; Olmez, Sedar. In: Papers. RePEc:arx:papers:2307.05581. Full description at Econpapers || Download paper |
2023 | The impact of monitor choice on insurer loss reserves. (2023). Sirmans, Eleanor Tice ; Montesinos, Hugo Moises ; McCullough, Kathleen ; Bisco, Jill. In: Risk Management and Insurance Review. RePEc:bla:rmgtin:v:26:y:2023:i:1:p:83-105. Full description at Econpapers || Download paper |
2023 | . Full description at Econpapers || Download paper |
2023 | The Right to Health and the Health Effects of Denials. (2023). Fernndez, Manuel ; Bhalotra, Sonia. In: CAGE Online Working Paper Series. RePEc:cge:wacage:660. Full description at Econpapers || Download paper |
2023 | A cost-benefit analysis of the medicines patent pool. (2023). Wang, Lucy Xiaolu. In: Economics Bulletin. RePEc:ebl:ecbull:eb-23-00047. Full description at Econpapers || Download paper |
2024 | Health policy, price regulation, and innovation: Evidence from China’s vaccine industry. (2024). Shi, Ce Matthew ; Geng, Hao. In: Journal of Development Economics. RePEc:eee:deveco:v:167:y:2024:i:c:s0304387823001852. Full description at Econpapers || Download paper |
2023 | Contingent factors of the coinsurance function of internal capital markets: Evidence from the US nonlife insurance industry. (2023). Shiu, Yung-Ming ; Hsiao, Ching-Yuan. In: The North American Journal of Economics and Finance. RePEc:eee:ecofin:v:66:y:2023:i:c:s1062940823000311. Full description at Econpapers || Download paper |
2023 | Risk-sharing function in internal capital markets: Evidence from intragroup reinsurance activities. (2023). Shiu, Yung-Ming ; Hsiao, Ching-Yuan. In: International Review of Financial Analysis. RePEc:eee:finana:v:87:y:2023:i:c:s1057521923001503. Full description at Econpapers || Download paper |
2023 | Are blockchain and cryptocurrency M&As harder to close?. (2023). Simsir, Serif Aziz ; Akdou, Evrim. In: Finance Research Letters. RePEc:eee:finlet:v:52:y:2023:i:c:s1544612322006766. Full description at Econpapers || Download paper |
2024 | The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis. (2024). Hollis, Aidan ; Grootendorst, Paul ; Guh, Daphne P ; Zhang, Wei ; Anis, Aslam H. In: Health Policy. RePEc:eee:hepoli:v:144:y:2024:i:c:s0168851024000745. Full description at Econpapers || Download paper |
2023 | Market for artificial intelligence in health care and compensation for medical errors. (2023). Musy, Olivier ; CHOPARD, Bertrand. In: International Review of Law and Economics. RePEc:eee:irlaec:v:75:y:2023:i:c:s0144818823000315. Full description at Econpapers || Download paper |
2024 | Market discipline and policy loans. (2024). Niehaus, Greg ; Chiang, Chia-Chun. In: Journal of Banking & Finance. RePEc:eee:jbfina:v:159:y:2024:i:c:s0378426623002716. Full description at Econpapers || Download paper |
2023 | The functions of known to be inaccurate prices in markets: A cross-country comparison of pharmaceutical list pricing. (2023). Krafve, Linus Johansson ; Sjogren, Ebba ; Kjellberg, Hans. In: Journal of Business Research. RePEc:eee:jbrese:v:167:y:2023:i:c:s0148296323005520. Full description at Econpapers || Download paper |
2024 | The interplay between product development failures and alliance portfolio properties in the formation of exploration versus exploitation alliances. (2024). Ozmel, Umit ; Bae, Joonhyung. In: Journal of Business Research. RePEc:eee:jbrese:v:177:y:2024:i:c:s0148296324001267. Full description at Econpapers || Download paper |
2023 | The short- and long-run effects of medical malpractice lawsuits on medical spending and hospital operations in China. (2023). Yi, Junjian ; Liu, Gordon ; Zhao, Shaoyang ; Yuan, YE. In: Journal of Comparative Economics. RePEc:eee:jcecon:v:51:y:2023:i:4:p:1142-1161. Full description at Econpapers || Download paper |
2023 | Negative network effects and public policy in vaccine markets. (2023). Tian, Jingwen ; Liu, Zhiwei ; Amir, Rabah. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:216:y:2023:i:c:p:136-149. Full description at Econpapers || Download paper |
2023 | Financing the litigation arms race. (2023). Grenadier, Steven R ; Antill, Samuel. In: Journal of Financial Economics. RePEc:eee:jfinec:v:149:y:2023:i:2:p:218-234. Full description at Econpapers || Download paper |
2023 | The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets. (2023). Straume, Odd Rune ; Dalen, Dag Morten ; Brekke, Kurt R. In: Journal of Health Economics. RePEc:eee:jhecon:v:90:y:2023:i:c:s0167629623000553. Full description at Econpapers || Download paper |
2023 | The effect of RCTs on drug demand: Evidence from off-label cancer drugs. (2023). McKibbin, Rebecca. In: Journal of Health Economics. RePEc:eee:jhecon:v:90:y:2023:i:c:s0167629623000565. Full description at Econpapers || Download paper |
2023 | Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis. (2023). Lu, You-Xun ; Hu, Mei-Ying ; Lai, Ching-Chong. In: Journal of Macroeconomics. RePEc:eee:jmacro:v:76:y:2023:i:c:s0164070423000198. Full description at Econpapers || Download paper |
2023 | The heterogeneous impacts of M&As on renewable energy firms’ innovation: Comparative analysis of China, the US and EU. (2023). Lv, Xin ; Dong, Weijia ; Qiao, LU. In: International Review of Economics & Finance. RePEc:eee:reveco:v:87:y:2023:i:c:p:306-323. Full description at Econpapers || Download paper |
2024 | Internal versus external capital markets and risk-taking. (2024). Shiu, Yung-Ming ; Hsiao, Ching-Yuan. In: International Review of Economics & Finance. RePEc:eee:reveco:v:92:y:2024:i:c:p:503-519. Full description at Econpapers || Download paper |
2023 | The role of patient organisations in research and development: Evidence from rare diseases. (2023). Miraldo, Marisa ; Gentilini, Arianna. In: Social Science & Medicine. RePEc:eee:socmed:v:338:y:2023:i:c:s0277953623006895. Full description at Econpapers || Download paper |
2023 | The role of government-industry-academia partnership in business incubation: Evidence from new R&D institutions in China. (2023). Wang, Mingyue ; Zhou, Junbi. In: Technology in Society. RePEc:eee:teinso:v:72:y:2023:i:c:s0160791x22003359. Full description at Econpapers || Download paper |
2023 | The Effects of Price Regulation on Pharmaceutical Expenditure and Availability. (2023). Toivanen, Otto ; Siikanen, Markku ; Markkanen, Jaakko ; Kortelainen, Mika. In: Working Papers. RePEc:fer:wpaper:157. Full description at Econpapers || Download paper |
2023 | Underwriting Cycles in Property-Casualty Insurance: The Impact of Catastrophic Events. (2023). Sattarhoff, Cristina ; Hofmann, Annette. In: Risks. RePEc:gam:jrisks:v:11:y:2023:i:4:p:75-:d:1121004. Full description at Econpapers || Download paper |
2023 | What do we know about startup-valuation drivers? A systematic literature review 1. (2023). le Pendeven, Benjamin ; Berre, Max. In: Post-Print. RePEc:hal:journl:hal-04232855. Full description at Econpapers || Download paper |
2023 | Does health technology assessment compromise access to pharmaceuticals?. (2023). Stargardt, Tom ; Bussgen, Melanie. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01484-4. Full description at Econpapers || Download paper |
2023 | Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier Effects. (2023). Exel, Job ; Hoefman, Renske ; Verbooy, Kaya ; Brouwer, Werner. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:9:d:10.1007_s40273-023-01253-y. Full description at Econpapers || Download paper |
2023 | Measuring the Indirect Cost of Illness Using EQ-5D-5L While Accounting for Job Characteristics. (2023). Jakubczyk, Micha ; Ko, Beata. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:9:d:10.1007_s40273-023-01267-6. Full description at Econpapers || Download paper |
2023 | Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic Review. (2023). Roijen, Leona Hakkaart ; Brouwer, Werner ; Hosseinnia, Nikkie ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:9:d:10.1007_s40273-023-01304-4. Full description at Econpapers || Download paper |
2023 | Pharmaceutical regulation under market integration through parallel trade. (2023). Birg, Laura. In: Canadian Journal of Economics/Revue canadienne d'économique. RePEc:wly:canjec:v:56:y:2023:i:4:p:1322-1346. Full description at Econpapers || Download paper |
2023 | Parallel imports under a manufacturer rebate and a price freeze: Evidence from Germany. (2023). Birg, Laura. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:2:p:302-323. Full description at Econpapers || Download paper |
2023 | Partially different? The importance of general equilibrium in health economic evaluations: An application to nocturia. (2023). Yerushalmi, Erez ; Burtea, Teodor ; Andersson, Fredrik L ; Hafner, Marco. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:3:p:654-674. Full description at Econpapers || Download paper |
2023 | . Full description at Econpapers || Download paper |
Year | Title | Type | Cited |
---|
Year | Title | Type | Cited |
---|---|---|---|
1988 | The Political Economy of Workers Compensation: Lessons for Product Liability. In: American Economic Review. [Full Text][Citation analysis] | article | 2 |
1990 | The Effects of Malpractice Litigation on Physicians Fees and Incomes. In: American Economic Review. [Full Text][Citation analysis] | article | 7 |
.() In: . [Full Text][Citation analysis] This paper has nother version. Agregated cites: 7 | paper | ||
1991 | Liability for Medical Malpractice In: Journal of Economic Perspectives. [Full Text][Citation analysis] | article | 81 |
2000 | Liability for medical malpractice.(2000) In: Handbook of Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 81 | chapter | |
1994 | Health Care Reform In: Australian Economic Review. [Full Text][Citation analysis] | article | 8 |
2004 | Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand In: Forum for Health Economics & Policy. [Full Text][Citation analysis] | article | 62 |
2004 | Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand.(2004) In: NBER Chapters. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 62 | chapter | |
2003 | Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand.(2003) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 62 | paper | |
1994 | The Swedish patient compensation system: Myths and realities In: International Review of Law and Economics. [Full Text][Citation analysis] | article | 3 |
2008 | Crises in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market In: Journal of Banking & Finance. [Full Text][Citation analysis] | article | 10 |
1997 | Price, Financial Quality, and Capital Flows in Insurance Markets In: Journal of Financial Intermediation. [Full Text][Citation analysis] | article | 104 |
2000 | Cross-national price differences for pharmaceuticals: how large, and why? In: Journal of Health Economics. [Full Text][Citation analysis] | article | 94 |
1982 | Hospital `profits : The effects of reimbursement policies In: Journal of Health Economics. [Full Text][Citation analysis] | article | 16 |
2002 | Welfare effects of supplementary insurance: a comment In: Journal of Health Economics. [Full Text][Citation analysis] | article | 10 |
2005 | Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances In: Journal of Health Economics. [Full Text][Citation analysis] | article | 84 |
2003 | Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances.(2003) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 84 | paper | |
1985 | Liability and liability insurance for medical malpractice In: Journal of Health Economics. [Full Text][Citation analysis] | article | 21 |
1984 | Separation of the redistributive and allocative functions of government : A public choice perspective In: Journal of Public Economics. [Full Text][Citation analysis] | article | 5 |
2012 | Regulation of the Biopharmaceutical Industry In: Chapters. [Full Text][Citation analysis] | chapter | 0 |
2012 | Effects of Regulation on Drug Launch and Pricing in Interdependent Markets In: Advances in Health Economics and Health Services Research. [Full Text][Citation analysis] | chapter | 28 |
2008 | Effects of Regulation on Drug Launch and Pricing in Interdependent Markets.(2008) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 28 | paper | |
1990 | THE EFFECTS OF MALPRACTICE LITIGATION ON PHYSICIANS FEES AND INCOME. In: University of Chicago - George G. Stigler Center for Study of Economy and State. [Citation analysis] | paper | 4 |
1990 | Mandated Employment-Based Health Insurance:Incidence and Efficiency Effects In: University of Chicago - George G. Stigler Center for Study of Economy and State. [Citation analysis] | paper | 2 |
2002 | Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy In: Center for Policy Research Policy Briefs. [Full Text][Citation analysis] | paper | 0 |
In: . [Full Text][Citation analysis] | paper | 0 | |
2007 | At what price? In: Nature. [Full Text][Citation analysis] | article | 3 |
2014 | Regulation of the Pharmaceutical-Biotechnology Industry In: NBER Chapters. [Full Text][Citation analysis] | chapter | 4 |
1999 | The Effects of Price Regulation on Productivity in Pharmaceuticals In: NBER Chapters. [Full Text][Citation analysis] | chapter | 2 |
2004 | Mergers and Acquisitions in the Pharmaceutical and Biotech Industries In: NBER Working Papers. [Full Text][Citation analysis] | paper | 78 |
2007 | Mergers and acquisitions in the pharmaceutical and biotech industries.(2007) In: Managerial and Decision Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 78 | article | |
2011 | Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement In: NBER Working Papers. [Full Text][Citation analysis] | paper | 15 |
2015 | Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement.(2015) In: Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 15 | article | |
2011 | Vaccine Supply: Effects Of Regulation And Competition In: NBER Working Papers. [Full Text][Citation analysis] | paper | 7 |
2011 | Vaccine Supply: Effects of Regulation and Competition.(2011) In: International Journal of the Economics of Business. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 7 | article | |
2011 | Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets In: NBER Working Papers. [Full Text][Citation analysis] | paper | 20 |
2012 | Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context In: NBER Working Papers. [Full Text][Citation analysis] | paper | 5 |
2002 | Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality In: NBER Working Papers. [Full Text][Citation analysis] | paper | 69 |
2003 | The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s In: NBER Working Papers. [Full Text][Citation analysis] | paper | 8 |
1997 | Trade and Price Differentials for Pharmaceuticals: Policy Options In: Monograph. [Full Text][Citation analysis] | book | 5 |
2000 | Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison In: Monograph. [Full Text][Citation analysis] | book | 4 |
2002 | The Life Cycle of Pharmaceuticals: A Cross-National Perspective In: Monograph. [Full Text][Citation analysis] | book | 6 |
2011 | Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution? In: Occasional Paper. [Full Text][Citation analysis] | paper | 2 |
1994 | Tort Reform: The Case of Medical Malpractice. In: Oxford Review of Economic Policy. [Citation analysis] | article | 1 |
1990 | Alternative Liability Regimes for Medical Injuries In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] | article | 4 |
1983 | Contingent Fees for Personal Injury Litigation In: Bell Journal of Economics. [Full Text][Citation analysis] | article | 53 |
2018 | Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues In: PharmacoEconomics. [Full Text][Citation analysis] | article | 13 |
2015 | Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? In: International Journal of the Economics of Business. [Full Text][Citation analysis] | article | 0 |
1997 | Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU In: International Journal of the Economics of Business. [Full Text][Citation analysis] | article | 33 |
1993 | The Economic Implications of Public Disability Insurance in the United States. In: Journal of Labor Economics. [Full Text][Citation analysis] | article | 13 |
2002 | Health Insurance and the Growth in Pharmaceutical Expenditures In: Journal of Law and Economics. [Full Text][Citation analysis] | article | 19 |
1984 | The Frequency and Severity of Medical Malpractice Claims. In: Journal of Law and Economics. [Full Text][Citation analysis] | article | 36 |
1993 | Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment. In: Journal of Law and Economics. [Full Text][Citation analysis] | article | 0 |
2000 | Does Regulation Drive out Competition in Pharmaceutical Markets? In: Journal of Law and Economics. [Full Text][Citation analysis] | article | 106 |
2001 | Workers Compensation Rate Regulation: How Price Controls Increase Costs. In: Journal of Law and Economics. [Full Text][Citation analysis] | article | 11 |
1997 | Tort Liability: A Minefield for Managed Care? In: The Journal of Legal Studies. [Full Text][Citation analysis] | article | 17 |
2001 | Comments on The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions. In: The Journal of Legal Studies. [Full Text][Citation analysis] | article | 0 |
1994 | Price Cutting in Liability Insurance Markets. In: The Journal of Business. [Full Text][Citation analysis] | article | 30 |
2000 | Rate Regulation, Safety Incentives, and Loss Growth in Workers Compensation Insurance. In: The Journal of Business. [Full Text][Citation analysis] | article | 6 |
2002 | A general model of the impact of absenteeism on employers and employees In: Health Economics. [Full Text][Citation analysis] | article | 42 |
1999 | Medical negligence and the NHS: an economic analysis In: Health Economics. [Full Text][Citation analysis] | article | 8 |
1995 | A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth In: Journal of Policy Analysis and Management. [Full Text][Citation analysis] | article | 0 |
1982 | Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00 In: Journal of Policy Analysis and Management. [Full Text][Citation analysis] | article | 0 |
1983 | Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95 In: Journal of Policy Analysis and Management. [Full Text][Citation analysis] | article | 0 |
1983 | Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50 In: Journal of Policy Analysis and Management. [Full Text][Citation analysis] | article | 1 |
2007 | Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion In: Managerial and Decision Economics. [Full Text][Citation analysis] | article | 6 |
In: . [Full Text][Citation analysis] | paper | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team